Loading…
Reported covered position: Legislative Counsel, House Energy & Commerce
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2015 · fourth_quarter · Q4
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2015 · third_quarter · Q3
Source: Senate LDA
| PURDUE PHARMA L.P. |
| 7 |
| 2012–2013 |
| SUNOVION PHARMACEUTICALS INC | 6 | 2009–2010 |
| SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION | 5 | 2009–2010 |
| COVIDIEN INC | 3 | 2013 |
| GW PHARMA INC. | 3 | 2015 |
| ST. JUDE MEDICAL, INC. | 3 | 2010 |
| AETNA, INC. | 2 | 2015 |
| ACTELION PHARMACEUTICALS US INC | 1 | 2011 |
| THE SSI GROUP | 1 | 2015 |
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: VIFOR PHARMA LTD · Firm: SIDLEY AUSTIN LLP
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Improving Regulatory Transparency for New Medical Therapies Act
Client: GW PHARMA INC. · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Improving Regulatory Transparency for New Medical Therapies Act
Client: GW PHARMA INC. · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Improving Regulatory Transparency for New Medical Therapies Act
Client: GW PHARMA INC. · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Putting Our Resources Toward Security (PORTS) Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Veterans Legal Support Act of 2013
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverageof A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
To suspend temporarily the duty on Disperse Blue 56.
Client: BAYER HEALTHCARE · Firm: SIDLEY AUSTIN LLP
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Medicare Patient Empowerment Act
Client: SOCIETY FOR VASCULAR ULTRASOUND · Firm: SIDLEY AUSTIN LLP
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act)
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Service Act
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Service Act
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client: SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION · Firm: SIDLEY AUSTIN LLP
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
America's Affordable Health Choices Act of 2009
Client: GRIFOLS INC · Firm: SIDLEY AUSTIN LLP
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Oil Spill Accountability and Environmental Protection Act of 2010
Client: GENENTECH · Firm: SIDLEY AUSTIN LLP
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
Issues related to biological reimbursements being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (Americas Affordable Health Choices Act of 2009), and Americas Healthy Future Act.
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure: S. 1145 and H.R. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), H.R. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Issues relating to patent law and patent procedure; S. 1145 and HR. 1908 (Patent Reform Act of 2007), S. 623 (Access to Life-Saving Medicine Act), HR. 5629 (Pathways and Biosimilars Act)
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GW PHARMA INC. via SIDLEY AUSTIN LLP
2015 · third_quarter · Q3
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Filing targets: SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2015 · second_quarter · Q2
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2015 · second_quarter · Q2
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GW PHARMA INC. via SIDLEY AUSTIN LLP
2015 · second_quarter · Q2
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Filing targets: SENATE
GW PHARMA INC. via SIDLEY AUSTIN LLP
2015 · second_quarter · RR
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
AETNA, INC. via SIDLEY AUSTIN LLP
2015 · second_quarter · 2T
Healthcare regulatory and legislative matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE SSI GROUP via SIDLEY AUSTIN LLP
2015 · second_quarter · RR
Health Care Privacy
AETNA, INC. via SIDLEY AUSTIN LLP
2015 · second_quarter · RR
Healthcare regulatory and legislative matters
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2015 · first_quarter · Q1
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2015 · first_quarter · Q1
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2014 · fourth_quarter · Q4
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2014 · fourth_quarter · Q4
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2014 · third_quarter · Q3
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2014 · third_quarter · Q3
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2014 · second_quarter · Q2
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2014 · second_quarter · Q2
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2014 · first_quarter · Q1
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act); advocate for ultrasound reimbursement under the Medicare PFS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2014 · first_quarter · 1T
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2014 · first_quarter · Q1
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2013 · fourth_quarter · Q4
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2013 · fourth_quarter · Q4
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2013 · fourth_quarter · Q4
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2013 · third_quarter · Q3
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2013 · third_quarter · Q3
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2013 · third_quarter · Q3
Patient access to abuse-deterent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2013 · third_quarter · Q3
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2013 · second_quarter · 2A
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2013 · second_quarter · Q2
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Educate federal agencies and congressional offices on the health policy reasons for the Medicare program to maintain its December 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2013 · second_quarter · Q2
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2013 · second_quarter · Q2
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2013 · second_quarter · Q2
Patient access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act, and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
COVIDIEN INC. via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Medicare reimbursement issues; diabetes care issues
340B Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2013 · first_quarter · Q1
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COVIDIEN INC. via SIDLEY AUSTIN LLP
2013 · first_quarter · RA
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
COVIDIEN INC. via SIDLEY AUSTIN LLP
2013 · first_quarter · RR
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
GRIFOLS INC via SIDLEY AUSTIN LLP
2012 · fourth_quarter · 4A
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act, and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
340B Issues
Medicare reimbursement issues; diabetes care issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2012 · fourth_quarter · Q4
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act, and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act; and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · third_quarter · Q3
340B Issues
Medicare reimbursement issues; diabetes care issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2012 · second_quarter · 2A
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · second_quarter · Q2
340B Issues
Medicare reimbursement issues; diabetes care issues
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2012 · second_quarter · Q2
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act; and healthcare deficit reduction proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2012 · second_quarter · Q2
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · second_quarter · Q2
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Ensuring that patients have access to abuse-deterrent pain relief drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Regulation of complex large-molecule drugs by the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act; and commentary on the AMP rule
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Changes to Medicare and Medicaid Services (CMS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2012 · first_quarter · Q1
Medicare reimbursement issues; diabetes care issues
340B Issues
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
VIFOR PHARMA LTD via SIDLEY AUSTIN LLP
2012 · first_quarter · RR
Regulation of complex large-molecule drugs by the Food and Drug Administration
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · third_quarter · 3A
Advocacy efforts with Congress and the Treasury Department relating to section 9008 of the Patient Protection and Affordable Care Act (Public Law 111-148), which creates an annual fee for manufacturers of branded prescription drugs based on sales to federal government health programs
Medicare reimbursement issues; diabetes care issues
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2011 · fourth_quarter · Q4
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the Care Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2011 · fourth_quarter · Q4
Implementation of Health Care Reform tax provisions.
Advocacy efforts relating to the drug-discount program under Section 340B of the Public Health Services Act; and healthcare deficit reduction proposals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2011 · fourth_quarter · Q4
Changes to Medicare and Medicaid Services (CMS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · fourth_quarter · Q4
340B Issues
Mediare reimbursement issues; diabetes care issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · third_quarter · Q3
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Advocacy efforts with Congress and the Treasury Department relating to section 9008 of the Patient Protection and Affordable Care Act (Public Law 111-148), which creates an annual fee for manufacturers of branded prescription drugs based on sales to federal government health programs
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2011 · third_quarter · Q3
Changes to Medicare and Medicaid Services (CMS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2011 · third_quarter · Q3
Advocacy efforts relating to section 9006 of the Patient Protection and Affordable Care Act (Public Law 111-148), which expands the scope of business activities that are subject to reporting tax-related information to the Internal Revenue Service through Form 1099; efforts relating to section 9008 of the Patient Protection and Affordable Care Act (Public Law 111-148), which creates an annual fee for manufacturers of braded prescription drugs based on sales to federal government health programs
Advocacy efforts in Congress relating to provision included in H.R. 4213 (the Tax Extenders Act of 2009), among other short titles) that would amend the drug-discount program under Section 340B of the Public Health Services Act
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2011 · third_quarter · Q3
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · second_quarter · 2A
Medicare reimbursement issues; diabetes care issues
Coverageof A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2011 · second_quarter · 2A
Changes to Medicare and Medicaid Services (CMS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2011 · second_quarter · Q2
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Advocacy efforts relating to section 9006 of the Patient Protection and Affordable Care Act (Public Law 111-148), which expands the scope of business activities that are subject to reporting tax-related information to the Internal Revenue Service through Form 1099; efforts relating to section 9008 of the Patient Protection and Affordable Care Act (Public Law 111-148), which creates an annual fee for manufacturers of branded prescription drugs based on sales to federal government health programs.
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2011 · second_quarter · Q2
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACTELION PHARMACEUTICALS US, INC. via SIDLEY AUSTIN LLP
2011 · second_quarter · RR
Advocacy efforts with Congress and the Treasury Department relating to section 9008 of the Patient Protection and Affordable Care Act (Public Law 111-148), which creates an annual fee for manufacturers of branded prescription drugs based on sales to federal government health programs.
GRIFOLS INC via SIDLEY AUSTIN LLP
2011 · first_quarter · Q1
Advocacy effort relating to section 9006 of the Patient Protection and Affordable Care Act (Public Law 111-148), which expands the scope of business activities that are subject to reporting tax-related information to the Internal Revenue Service through Form 1099; efforts relating to section 9008 of the Patient Protection and Affordable Care Act (Public Law 111-148), which creates an annual fee for manufacturers of branded prescription drugs based on sales to federal government health programs.
Advocacy efforts in Congres relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
SOCIETY FOR VASCULAR ULTRASOUND via SIDLEY AUSTIN LLP
2011 · first_quarter · Q1
Medicare coverage for ultrasound services; H.R. 583 and S. 1042 (the CARE Act)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2011 · first_quarter · Q1
Changes to Medicare and Medicaid Services (CMS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2011 · first_quarter · Q1
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Medicare reimbursement issues; diabetes care issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2010 · fourth_quarter · Q4
Medicaid Federal Upper Limit on drug reimbursement concerns
Changes to Medicare and Medicaid Services (CMS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2010 · fourth_quarter · Q4
Advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Advocacy efforts in Congress relating to section 9006 of the Patient Protection and Affordable Care Act (Public Law 111-148), which expands the scope of business activities that are subject to reporting tax-related information to the Internal Revenue Service through Form 1099
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2010 · fourth_quarter · Q4
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Medicare reimbursement issues; diabetes care issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Advocacy efforts in Congress relating to section 9006 of the Patient Protection and Affordable Care Act (Public Law 111-148), which expands the scope of business activities that are subject to reporting tax-related information to the Internal Revenue Service through Form 1099
ST. JUDE MEDICAL, INC. via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Issues relating to 510K clearance for medical devices regulated under the Federal Food, Drug and Cosmetic Act
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Changes to Medicare and Medicaid Services (CMS)
Medicaid Federal Upper Limit on drug reimbursement concerns
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among the other short titles) that would amend the drug-discount program under section 340B of the Public Health Service Act
Medicare reimbursement issues; diabetes care issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2010 · third_quarter · Q3
Medicare reimbursement issues; opposition to use of price referencing; health care reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ST. JUDE MEDICAL, INC. via SIDLEY AUSTIN LLP
2010 · third_quarter · RA
Issues relating to 510K clearance for medical devices regulated under the Federal Food, Drug and Cosmetic Act
ST. JUDE MEDICAL, INC. via SIDLEY AUSTIN LLP
2010 · third_quarter · RR
Issues relating to 510K, Medical clearance for devices regulated under the Federal Food, Drug and Cosmetic Act
GRIFOLS INC via SIDLEY AUSTIN LLP
2010 · second_quarter · Q2
Advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Service Act
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Advocacy efforts in Congress relating to section 9006 of the Patient Protection and Affordable Care Act (Public Law 111-148), which expands the scope of business activities that are subject to reporting tax-related information to the Internal Revenue Service through Form 1099
GENENTECH via SIDLEY AUSTIN LLP
2010 · second_quarter · Q2
H.R. 3590 (Patient Protection and Affordable Care Act of 2010)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via SIDLEY AUSTIN LLP
2010 · second_quarter · Q2
Medicaid Federal Upper Limit on drug reimbursement concerns
Changes to Medicare, Federal Upper Limit
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAYER HEALTHCARE via SIDLEY AUSTIN LLP
2010 · second_quarter · Q2
Medicare reimbursement issues; diabetes care issues
Coverage of A1c diabetes test H.R. 3962 (the Affordable Health Care for America Act); advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Service Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS INC via SIDLEY AUSTIN LLP
2010 · second_quarter · Q2
Medicare reimbursement issues; opposition to use of price referencing; health care reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION via SIDLEY AUSTIN LLP
2010 · second_quarter · 2T
Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2010 · first_quarter · 1A
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GRIFOLS INC via SIDLEY AUSTIN LLP
2010 · first_quarter · Q1
Issues related to biological reimbursement being considered in health care reform legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare reimbursement issues; diabetes care issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 340B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choice Act of 2009) and America's Healthy Future Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Advocacy efforts in Congress relating to provisions included in H.R. 4213 (the Tax Extenders Act of 2009, among other short titles) that would amend the drug-discount program under section 340B of the Public Health Services Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Issues related to biological reimbursement being considered in legislation and to Medicare, Medicaid and Health Care reform, including Medicaid rebates, IVIG access and 3408B expansion, H.R. 3200 and S. 1679 (America's Affordable Health Choices Act of 2009) and America's Healthy Future Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of